Skip to main content

Peer Review reports

From: Efficacy of galcanezumab in patients with migraine who did not benefit from commonly prescribed preventive treatments

Original Submission
29 Jan 2021 Submitted Original manuscript
15 Feb 2021 Reviewed Reviewer Report - Luigi Alberto Pini
3 Mar 2021 Reviewed Reviewer Report - Piero Barbanti
22 Mar 2021 Author responded Author comments - Dulanji K. Kuruppu
Resubmission - Version 2
22 Mar 2021 Submitted Manuscript version 2
Publishing
7 Apr 2021 Editorially accepted
23 Apr 2021 Article published 10.1186/s12883-021-02196-7

You can find further information about peer review here.

Back to article page